It’s been 4,000 years since the woolly mammoth went extinct, but Dallas-based Colossal Biosciences wants to change that. In 2022, it announced it had sequenced the genome of the Asian elephant, which shares 99.6% of its genes with the woolly mammoth. Combining that with DNA samples from mammoth remains could mean a rebirth of the species. The company hopes to work its “de-extinction” magic on other species, including the dodo and the Tasmanian tiger, and threatened species could be saved from extinction by editing more diversity into their genomes, making them more robust.
A weekly newsletter featuring conversations with the world’s top CEOs, managers, and founders. Join the Leadership Brief.
More Must-Reads from TIME
- Where Trump 2.0 Will Differ From 1.0
- How Elon Musk Became a Kingmaker
- The Power—And Limits—of Peer Support
- The 100 Must-Read Books of 2024
- Column: If Optimism Feels Ridiculous Now, Try Hope
- The Future of Climate Action Is Trade Policy
- FX’s Say Nothing Is the Must-Watch Political Thriller of 2024
- Merle Bombardieri Is Helping People Make the Baby Decision